Results 141 to 150 of about 8,896 (223)

Effect of hyperthermic intraperitoneal chemotherapy on patients with advanced colorectal cancer: a systematic review and meta-analysis. [PDF]

World J Surg Oncol
Su Z, Guo Y, Ru X, Wang X, Mao Q, Zhou N, Xu Z, Huang L, Ge C, Hong Y, He F, Hu M.   +11 more
europepmc   +1 more source

Peritoneal carcinomatosis management through cytoreductive surgery with hyperthermic intraperitoneal chemotherapy: first experience in Iraq. [PDF]

Front Oncol
Mahmood AS, Al-Obaidi AD, Al-Obaidi MN, Madlul YA, Al Sakini AS, Hashim HT, Shakir AA, Qassim T, Ahmed Shimal A, Ahmed MJ, Mohammed FEA, Al-Obaidi H.   +11 more
europepmc   +1 more source

Efficacy and safety of sequential hyperthermic intraperitoneal chemotherapy following surgery for pathological T staging 4 gastric cancer. [PDF]

World J Gastroenterol
Lian WL, Cai LS, Lian MQ, Lian MJ, Sun YQ, Lv CB, Huang GP, Huang RJ, Zhang YB, Zeng WM, Xu QH, Zhu QJ, Chen QX.   +12 more
europepmc   +1 more source

The Role of Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Peritoneal GIST-Induced Sarcomatosis (GISTosis). [PDF]

J Clin Med
Spiliotis J, Kopanakis N, Rogdakis A, Peppas G, Fotiadou A, Evangelou K, Vassos N.   +6 more
europepmc   +1 more source

Effects of argipressin on intraoperative fluid administration in cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS-HIPEC): study protocol of a randomised clinical trial (HiPress Trial). [PDF]

BMJ Open
van Zwol J, Aalbers AGJ, van den Brom CE, Hollmann MW, Hulst AH, Lameris W, Tuinman PR, Vlaar APJ, Veelo DP, Hemmes SNT.   +9 more
europepmc   +1 more source

Quality of life following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: a Canadian experience. [PDF]

Can J Surg
Taqi K, Stockley C, Fyfe A, Temple W, Mack L, Bouchard-Fortier A.   +5 more
europepmc   +1 more source

Propensity score-matched evaluation of prophylactic hyperthermic intraperitoneal chemotherapy in geriatric patients with locally advanced colorectal cancer: safety and survival benefits. [PDF]

BMC Cancer
Yang M, Yang S, Zhang W, Ma F, Yu T.
europepmc   +1 more source

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy can be safely combined with nephrectomy in patients with appendiceal malignancy and synchronous renal cell carcinoma. [PDF]

J Surg Case Rep
Kok SY, Mohamed F, Moran BJ, Dayal S, Tzivanakis A, Hindley R, Emara A, Cecil T.   +7 more
europepmc   +1 more source

Functional and multimodal approach to sarcopenia in cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. [PDF]

Int J Colorectal Dis
Demirli Atici S, Canda AE, Terzi MC.
europepmc   +1 more source